5-fluoro-2-hydroxy-4-[6-[4-methyl-2-(pyridin-2-yloxymethyl)-1,3-thiazol-5-yl]-2-pyridinyl]benzoic acid
C22H16FN3O4S — CID 162757209
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-fluoro-2-hydroxy-4-[6-[4-methyl-2-(pyridin-2-yloxymethyl)-1,3-thiazol-5-yl]-2-pyridinyl]benzoic acid
5-fluoro-2-hydroxy-4-[6-[4-methyl-2-(pyridin-2-yloxymethyl)-1,3-thiazol-5-yl]-2-pyridinyl]benzoic acid (PubChem CID 162757209) has the molecular formula C22H16FN3O4S and a molecular weight of 437.45 g/mol. Its IUPAC name is 5-fluoro-2-hydroxy-4-[6-[4-methyl-2-(pyridin-2-yloxymethyl)-1,3-thiazol-5-yl]-2-pyridinyl]benzoic acid.
Molecular Properties
| Compound Name | 5-fluoro-2-hydroxy-4-[6-[4-methyl-2-(pyridin-2-yloxymethyl)-1,3-thiazol-5-yl]-2-pyridinyl]benzoic acid |
|---|---|
| PubChem CID | 162757209 |
| Molecular Formula | C22H16FN3O4S |
| Molecular Weight | 437.45 g/mol |
| Exact Mass | 437.08 |
| IUPAC Name | 5-fluoro-2-hydroxy-4-[6-[4-methyl-2-(pyridin-2-yloxymethyl)-1,3-thiazol-5-yl]-2-pyridinyl]benzoic acid |
| SMILES | Cc1nc(COc2ccccn2)sc1-c1cccc(-c2cc(O)c(C(=O)O)cc2F)n1 |
| InChI | InChI=1S/C22H16FN3O4S/c1-12-21(31-20(25-12)11-30-19-7-2-3-8-24-19)17-6-4-5-16(26-17)13-10-18(27)14(22(28)29)9-15(13)23/h2-10,27H,11H2,1H3,(H,28,29) |
| InChIKey | BPFNPWUQDOBECZ-UHFFFAOYSA-N |
| XLogP | 4.70 |
| TPSA | 105.43 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.45 |
| LogP ≤ 5 | 4.70 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162757209 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.